Ipamorelin is a synthetic 5-amino acid growth hormone releasing peptide studied for selective GH secretion in research models. ≥99% HPLC-verified. For research use only.
Selective growth hormone secretagogue with ghrelin receptor activity
Every lot independently verified by third-party laboratories
Full Certificate of Analysis with HPLC, mass spec, and endotoxin data
Ipamorelin is a synthetic pentapeptide growth hormone secretagogue (GHS) that selectively stimulates the ghrelin/GHS receptor. Unlike other GHS peptides, research indicates Ipamorelin has high selectivity for GH release in preclinical models.
Developed by Novo Nordisk in the 1990s, Ipamorelin has been studied in multiple clinical trials. Published research has examined its receptor binding selectivity and pharmacokinetic properties compared to other GH secretagogues.
Manufactured under cGMP-equivalent protocols and verified to ≥99% purity via HPLC. Full COA included with every order.
Supplied as a lyophilized white powder. Soluble in sterile water and bacteriostatic water. For research and laboratory use only.
Ipamorelin is a synthetic pentapeptide growth hormone secretagogue that selectively targets the ghrelin/GHS receptor. It is intended exclusively for in-vitro and laboratory research.
Verified at ≥99% purity via reverse-phase HPLC. Each lot includes mass spectrometry confirmation and endotoxin testing. Full COA included.
Lyophilized: -20°C long-term, stable at 2–8°C for 90 days. Reconstituted: 2–8°C, use within 28 days. Protect from light.
Yes. Every order includes a lot-specific COA with HPLC chromatography, mass spec data, peptide content, and endotoxin levels.
Orders before 2PM EST ship same day. Standard delivery is 2–4 business days within the continental US. All orders include tracking.
Still have questions about Ipamorelin or any of our research compounds?
Contact Our Research Team →
